Amy had a meeting at the lab on Wednesday and welcomed two new members to the team!
Dr Paul Cross is a GCP (Good Clinical Practice) consultant who is working with us both in the set up of the Vaccine phase II trial at GSTT and the work on the MAP test in the lab at KCL. His role is to help us develop systems to ensure that our research is conducted to the highest standards. The complexity of rules and regulations can be quite scary so to have someone on the team with his wisdom and expertise in this area is an absolute godsend!
Dr Gaurav Agrawal is a Consultant Gastroenterologist who is joining our team as a Clinical Research Fellow and will be working alongside Prof Jeremy Sanderson to lead the Phase II Vaccine clinical trial at GSTT. He’s come all the way from Centre for Digestive Diseases (CDD), Sydney, where he’s been Prof Borody’s right-hand man for the last few years, leading the way in MAP research as well as looking after many Crohn’s patients, taking a MAP-targeted approach to treatment. Initially his involvement will be for at least six months, then he will be splitting his time between GSTT (until the trial is complete) and CDD. He is a wonderful doctor and passionate about this area of research.
The team, from left to right:
Barry Hudspith, Senior research technician
Neil Rayment, Senior research scientist
Dr Paul Cross, GCP consultant
Prof John Hermon-Taylor, project leader
Dr Gaurav Agrawal, Consultant Gastroenterologist and Clinical Research Fellow
Dr Amy Hermon-Taylor